Meridian Bioscience Inc.

NASDAQ:VIVO   4:00:00 PM EDT
31.71
-0.29 (-0.91%)
4:05:10 PM EDT: $31.71 0.00 (0.00%)
Earnings Announcements

Meridian Bioscience Reports Q4 results

Published: 11/22/2022 13:13 GMT
Meridian Bioscience Inc. (VIVO) - Meridian Bioscience Reports Fourth Quarter and Full Year Fiscal 2022 Operating Results.
Meridian Bioscience Inc Q4 Revenue Rose 5 Percent to $333.0 Million.
Meridian Bioscience Inc - Qtrly Diluted EPS of $0.13.
Meridian Bioscience Inc - Qtrly Adjusted Diluted EPS of $0.20.
Revenue is expected to be $78.6 Million
Adjusted EPS is expected to be $0.25

Next Quarter Revenue Guidance is expected to be $75.7 Million
Next Quarter EPS Guidance is expected to be $0.24

More details on our Analysts Page.